정밀의료 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Precision Medicine Market size is anticipated to grow from USD 79.45 Billion in 2024 to USD 329.69 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.13% during the forecast period of 2026 to 2033.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

• Bioinformatics
• Big Data Analytics
• Drug Discovery
• Gene Sequencing
• Companion Diagnostics
• Others

By Application

• CNS
• Immunology
• Oncology
• Respiratory
• Others

By End-Use

• Diagnostic Companies
• Pharmaceutical Companies
• Healthcare IT companies
• Others

By Sequencing Technology

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single Molecule Real Time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing

By Product

• Consumables
• Instruments
• Services

By Route of Administration

• Oral
• Injectable

By Drugs

• Alectinib
• Osimertinib
• Mepolizumab
• Aripiprazole Lauroxil
• Others
• COMPANIES PROFILED
• Biocrates Life Sciences
• Tepnel Pharma Services
• Novartis
• Qiagen
• Quest Diagnostics
• Menarini Silicon Biosystems
• NanoString Technologies
• Eagle Genomics
• Pfizer
• Intomics
• Roche
• Teva Pharmaceutical
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PRECISION MEDICINE INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-Use
  • 3.7.4 Market Attractiveness Analysis By Sequencing Technology
  • 3.7.5 Market Attractiveness Analysis By Product
  • 3.7.6 Market Attractiveness Analysis By Route of Administration
  • 3.7.7 Market Attractiveness Analysis By Drugs
  • 3.7.8 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

• 5.1. Overview By Technology
• 5.2. Historical and Forecast Data Analysis By Technology
• 5.3. Bioinformatics Historic and Forecast Sales By Regions
• 5.4. Big Data Analytics Historic and Forecast Sales By Regions
• 5.5. Drug Discovery Historic and Forecast Sales By Regions
• 5.6. Gene Sequencing Historic and Forecast Sales By Regions
• 5.7. Companion Diagnostics Historic and Forecast Sales By Regions
• 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. CNS Historic and Forecast Sales By Regions
• 6.4. Immunology Historic and Forecast Sales By Regions
• 6.5. Oncology Historic and Forecast Sales By Regions
• 6.6. Respiratory Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-Use
• 7.2. Historical and Forecast Data Analysis By End-Use
• 7.3. Diagnostic Companies Historic and Forecast Sales By Regions
• 7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
• 7.5. Healthcare IT companies Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY

• 8.1. Overview By Sequencing Technology
• 8.2. Historical and Forecast Data Analysis By Sequencing Technology
• 8.3. Sequencing by Synthesis Historic and Forecast Sales By Regions
• 8.4. Ion Semiconductor Sequencing Historic and Forecast Sales By Regions
• 8.5. Sequencing by Ligation Historic and Forecast Sales By Regions
• 8.6. Pyrosequencing Historic and Forecast Sales By Regions
• 8.7. Single Molecule Real Time Sequencing Historic and Forecast Sales By Regions
• 8.8. Chain Termination Sequencing Historic and Forecast Sales By Regions
• 8.9. Nanopore Sequencing Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY PRODUCT

• 9.1. Overview By Product
• 9.2. Historical and Forecast Data Analysis By Product
• 9.3. Consumables Historic and Forecast Sales By Regions
• 9.4. Instruments Historic and Forecast Sales By Regions
• 9.5. Services Historic and Forecast Sales By Regions

10. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 10.1. Overview By Route of Administration
• 10.2. Historical and Forecast Data Analysis By Route of Administration
• 10.3. Oral Historic and Forecast Sales By Regions
• 10.4. Injectable Historic and Forecast Sales By Regions

11. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY DRUGS

• 11.1. Overview By Drugs
• 11.2. Historical and Forecast Data Analysis By Drugs
• 11.3. Alectinib Historic and Forecast Sales By Regions
• 11.4. Osimertinib Historic and Forecast Sales By Regions
• 11.5. Mepolizumab Historic and Forecast Sales By Regions
• 11.6. Aripiprazole Lauroxil Historic and Forecast Sales By Regions
• 11.7. Others Historic and Forecast Sales By Regions

12. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

• 12.1. Regional Outlook
• 12.2. Introduction
• 12.3. North America Sales Analysis
  • 12.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 12.3.2 North America By Segment Sales Analysis
  • 12.3.3 North America By Country Sales Analysis
  • 12.3.4 United States Sales Analysis
  • 12.3.5 Canada Sales Analysis
  • 12.3.6 Mexico Sales Analysis
• 12.4. Europe Sales Analysis
  • 12.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 12.4.2 Europe By Segment Sales Analysis
  • 12.4.3 Europe By Country Sales Analysis
  • 12.4.4 United Kingdom Sales Analysis
  • 12.4.5 France Sales Analysis
  • 12.4.6 Germany Sales Analysis
  • 12.4.7 Italy Sales Analysis
  • 12.4.8 Russia Sales Analysis
  • 12.4.9 Rest Of Europe Sales Analysis
• 12.5. Asia Pacific Sales Analysis
  • 12.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 12.5.2 Asia Pacific By Segment Sales Analysis
  • 12.5.3 Asia Pacific By Country Sales Analysis
  • 12.5.4 China Sales Analysis
  • 12.5.5 India Sales Analysis
  • 12.5.6 Japan Sales Analysis
  • 12.5.7 South Korea Sales Analysis
  • 12.5.8 Australia Sales Analysis
  • 12.5.9 South East Asia Sales Analysis
  • 12.5.10 Rest Of Asia Pacific Sales Analysis
• 12.6. Latin America Sales Analysis
  • 12.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 12.6.2 Latin America By Segment Sales Analysis
  • 12.6.3 Latin America By Country Sales Analysis
  • 12.6.4 Brazil Sales Analysis
  • 12.6.5 Argentina Sales Analysis
  • 12.6.6 Peru Sales Analysis
  • 12.6.7 Chile Sales Analysis
  • 12.6.8 Rest of Latin America Sales Analysis
• 12.7. Middle East & Africa Sales Analysis
  • 12.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 12.7.2 Middle East & Africa By Segment Sales Analysis
  • 12.7.3 Middle East & Africa By Country Sales Analysis
  • 12.7.4 Saudi Arabia Sales Analysis
  • 12.7.5 UAE Sales Analysis
  • 12.7.6 Israel Sales Analysis
  • 12.7.7 South Africa Sales Analysis
  • 12.7.8 Rest Of Middle East And Africa Sales Analysis

13. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

• 13.1. Precision Medicine Market Competition
• 13.2. Partnership/Collaboration/Agreement
• 13.3. Merger And Acquisitions
• 13.4. New Product Launch
• 13.5. Other Developments

14. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

• 14.1. Top Companies Market Share Analysis
• 14.2. Market Concentration Rate
• 14.3. Biocrates Life Sciences
  • 14.3.1 Company Overview
  • 14.3.2 Company Revenue
  • 14.3.3 Products
  • 14.3.4 Recent Developments
• 14.4. Tepnel Pharma Services
  • 14.4.1 Company Overview
  • 14.4.2 Company Revenue
  • 14.4.3 Products
  • 14.4.4 Recent Developments
• 14.5. Novartis
  • 14.5.1 Company Overview
  • 14.5.2 Company Revenue
  • 14.5.3 Products
  • 14.5.4 Recent Developments
• 14.6. Qiagen
  • 14.6.1 Company Overview
  • 14.6.2 Company Revenue
  • 14.6.3 Products
  • 14.6.4 Recent Developments
• 14.7. Quest Diagnostics
  • 14.7.1 Company Overview
  • 14.7.2 Company Revenue
  • 14.7.3 Products
  • 14.7.4 Recent Developments
• 14.8. Menarini Silicon Biosystems
  • 14.8.1 Company Overview
  • 14.8.2 Company Revenue
  • 14.8.3 Products
  • 14.8.4 Recent Developments
• 14.9. NanoString Technologies
  • 14.9.1 Company Overview
  • 14.9.2 Company Revenue
  • 14.9.3 Products
  • 14.9.4 Recent Developments
• 14.10. Eagle Genomics
  • 14.10.1 Company Overview
  • 14.10.2 Company Revenue
  • 14.10.3 Products
  • 14.10.4 Recent Developments
• 14.11. Pfizer
  • 14.11.1 Company Overview
  • 14.11.2 Company Revenue
  • 14.11.3 Products
  • 14.11.4 Recent Developments
• 14.12. Intomics
  • 14.12.1 Company Overview
  • 14.12.2 Company Revenue
  • 14.12.3 Products
  • 14.12.4 Recent Developments
• 14.13. Roche
  • 14.13.1 Company Overview
  • 14.13.2 Company Revenue
  • 14.13.3 Products
  • 14.13.4 Recent Developments
• 14.14. Teva Pharmaceutical
  • 14.14.1 Company Overview
  • 14.14.2 Company Revenue
  • 14.14.3 Products
  • 14.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies